Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Aug 16, 2024

SELL
$30.32 - $91.33 $212 - $639
-7 Closed
0 $0
Q4 2021

Aug 16, 2024

BUY
$86.26 - $119.0 $603 - $833
7 New
7 $654,000
Q2 2021

Aug 16, 2024

BUY
$86.05 - $119.72 $5,335 - $7,422
62 New
62 $7.04 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $13B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.